Skip to main content

Neutra Corp

corporate_fare Company Profile

Neutra Corp

NTRR·OTC·Life Sciences·CIK 0001512886

Neutra Corp is a company focused on the nutraceutical space, marketing and participating in products derived from natural and organic origins. The company was incorporated in Nevada on January 11, 2011, and reincorporated in Wyoming on August 16, 2019. Neutra Corp plans to research and introduce new technology to the nutraceutical space, which focuses on natural remedies and the body's ability to heal itself. This includes participation in the medical cannabis market, a sub-market of nutraceuticals. The company intends to use a nutraceutical contractor to private label all its products, selling them under its own brand. Neutra Corp's fiscal year ends on January 31. The company actively seeks new technologies and products for the global cannabis market, covering areas such as lighting, dosage devices, pesticide replacements, and plant enhancers. On January 23, 2018, Neutra Corp entered into an agreement with Artillery Labs to sell and market natural nutraceuticals online, specifically its own line of all-natural and legal CBD products, utilizing Artillery Labs' online sales infrastructure. Artillery Labs is to be paid $25,000 upon the successful marketing launch of a product. On August 30, 2019, Neutra Corp acquired all outstanding stock of Vivis Corporation, a Wyoming corporation, from Sydney Jim, the CEO. The purchase price for Vivis was $35,000 cash, plus a royalty of 40 percent of gross revenue until $100,000 is paid, declining to 25 percent until an additional $100,000 has been paid, followed by a 10 percent royalty in perpetuity.

Neutra Corp (OTC:NTRR) is a publicly traded company in the Life Sciences sector. Wiseek monitors NTRR SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Neutra Life Sciences Forms Women's Health JV, Secures New Clinical Trials
Browse all tickers starting with N →
$0.0001
52-week range · as of 2026-06-29 $0.000001 – $0.0003
Market cap
$291.79K
Volume
65.5K (0.1× avg)
3-mo avg 1.3M
Live data · 2026-08-14 04:00 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed NTRR - Latest Insights

NTRR
Jun 29, 2026, 3:29 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.0001
Real-time Price: $0.0001 info
Change: $0 (0%) info
Market Cap: $291.79K info